New guidance on use of infliximab in ulcerative colitis

31 December 2008

NICE has issued guidance on the use of infliximab for the treatment of acute exacerbations of ulcerative colitis.

The guidance states that infliximab should only be used in people with acute, severely active ulcerative colitis if treatment with ciclosporin is contraindicated or clinically inappropriate, or if they are taking part in a clinical trial.

A summary of the new guidance is available at www.mims.co.uk.  To read the full guidance visit the NICE website.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

The most up-to-date drug information at your fingertips.

  • Get the prescribing support you need.
  • Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Register Now
Already Registered?

Forgotten password?

More from MIMS

Products coming soon - live tracker

EXCLUSIVE TO SUBSCRIBERS Monitor forthcoming UK drug...

Deleted products - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest products removed...

Drug shortages - live tracker

EXCLUSIVE TO SUBSCRIBERS Use our constantly updated...

Pregnant woman having an ultrasound scan with a female sonographer

Valproate prescribing: plan for new regulatory measures without delay, instructs MHRA

A National Patient Safety Alert (NatPSA) has been issued...